Obsidian FlamesObsidian Flames🃏All Larvesta cards
Ask about Larvesta
Larvesta #40 Pokémon card from Obsidian Flames

Larvesta 40/197

Obsidian Flames

Find this card on eBay

Affiliate link · we may earn commission

Larvesta #40 from Obsidian Flames currently trades at $0.84 raw, with PSA 10 copies reaching $34.99 — a 41.7x grade premium.
Current Prices (USD)
Ungraded
$0.84
PSA 7
$11.43
PSA 8
$11.43
PSA 9
$11.43
PSA 10
$34.99
ACE 10
BGS 10 Black
$225.00
CGC 10 Pristine
$38.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Larvesta 40/197 from Obsidian Flames has a current raw market value of $0.84.

Current raw value
$0.84
PSA 9 value
$11.43
PSA 10 value
$34.99
PSA 10 premium vs raw
41.7× raw
View all cards from Obsidian Flames
Collector Intel
41.7x
Raw → PSA 10
High-risk grade
13.6x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 42x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$35
PSA 10 Value
+$9
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1113.6x raw
PSA 10$3541.7x raw

Frequently asked questions

How much is Larvesta #40 from Obsidian Flames worth?+
Larvesta #40 from Obsidian Flames is currently worth Raw: $0.84, PSA 9: $11.43, PSA 10: $34.99 based on recent sold listings. Prices update daily from real eBay sales.
Is Larvesta #40 worth grading?+
The PSA 10 price of $34.99 is 41.7× the raw price of $0.84. After a ~$25 grading fee, a PSA 10 result would net approximately $34.15 — assuming the card grades a 10.
Where do PokePrices Larvesta #40 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.